Cargando…

Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()

OBJECTIVES: To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380 A (TCu380A) intrauterine device. STUDY DESIGN: This was an open-label 7-year randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Patrick, Farley, Tim, Peregoudov, Alexandre, Piaggio, Gilda, Boccard, Simone, Landoulsi, Sihem, Meirik, Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357727/
https://www.ncbi.nlm.nih.gov/pubmed/26916172
http://dx.doi.org/10.1016/j.contraception.2016.02.024
_version_ 1782516090480361472
author Rowe, Patrick
Farley, Tim
Peregoudov, Alexandre
Piaggio, Gilda
Boccard, Simone
Landoulsi, Sihem
Meirik, Olav
author_facet Rowe, Patrick
Farley, Tim
Peregoudov, Alexandre
Piaggio, Gilda
Boccard, Simone
Landoulsi, Sihem
Meirik, Olav
author_sort Rowe, Patrick
collection PubMed
description OBJECTIVES: To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380 A (TCu380A) intrauterine device. STUDY DESIGN: This was an open-label 7-year randomized controlled trial in 20 centres, 11 of which in China. Data on 1884 women with interval insertion of the LNG-IUD and 1871 of the TCu380A were analysed using life tables with 30-day intervals and Cox proportional hazards models. RESULTS: The cumulative 7-year pregnancy rate of the LNG-IUD was 0.5 (standard error 0.2) per 100, significantly lower than 2.5 (0.4) per 100 of the TCu380A, cumulative method discontinuation rates at 7 years were 70.6 (1.2) and 40.8 (1.3) per 100, respectively. Dominant reasons for discontinuing the LNG-IUD were amenorrhea (26.1 [1.3] per 100) and reduced bleeding (12.5 [1.1] per 100), particularly in Chinese women and, for the TCu380A, increased bleeding (9.9 [0.9] per 100), especially among non-Chinese women. Removal rates for pain were similar for the two intrauterine devices (IUDs). Cumulative rates of removal for symptoms compatible with hormonal side effects were 5.7 (0.7) and 0.4 (0.2) per 100 for the LNG-IUD and TCu380A, respectively, and cumulative losses to follow-up at 7 years were 26.0 (1.4) and 36.9 (1.3) per 100, respectively. CONCLUSION: The LNG-IUD and the TCu380A have very high contraceptive efficacy, with the LNG-IUD significantly higher than the TCu380A. Overall rates of IUD removals were higher among LNG-IUD users than TCu380A users. Removals for amenorrhea appeared culturally associated. IMPLICATIONS: The 52-mg LNG-IUD and the TCu380A have very high contraceptive efficacy through 7 years. As an IUD, the unique side effects of the LNG-IUD are reduced bleeding, amenorrhea and symptoms compatible with hormonal contraceptives.
format Online
Article
Text
id pubmed-5357727
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53577272017-03-28 Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()() Rowe, Patrick Farley, Tim Peregoudov, Alexandre Piaggio, Gilda Boccard, Simone Landoulsi, Sihem Meirik, Olav Contraception Original Research Article OBJECTIVES: To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380 A (TCu380A) intrauterine device. STUDY DESIGN: This was an open-label 7-year randomized controlled trial in 20 centres, 11 of which in China. Data on 1884 women with interval insertion of the LNG-IUD and 1871 of the TCu380A were analysed using life tables with 30-day intervals and Cox proportional hazards models. RESULTS: The cumulative 7-year pregnancy rate of the LNG-IUD was 0.5 (standard error 0.2) per 100, significantly lower than 2.5 (0.4) per 100 of the TCu380A, cumulative method discontinuation rates at 7 years were 70.6 (1.2) and 40.8 (1.3) per 100, respectively. Dominant reasons for discontinuing the LNG-IUD were amenorrhea (26.1 [1.3] per 100) and reduced bleeding (12.5 [1.1] per 100), particularly in Chinese women and, for the TCu380A, increased bleeding (9.9 [0.9] per 100), especially among non-Chinese women. Removal rates for pain were similar for the two intrauterine devices (IUDs). Cumulative rates of removal for symptoms compatible with hormonal side effects were 5.7 (0.7) and 0.4 (0.2) per 100 for the LNG-IUD and TCu380A, respectively, and cumulative losses to follow-up at 7 years were 26.0 (1.4) and 36.9 (1.3) per 100, respectively. CONCLUSION: The LNG-IUD and the TCu380A have very high contraceptive efficacy, with the LNG-IUD significantly higher than the TCu380A. Overall rates of IUD removals were higher among LNG-IUD users than TCu380A users. Removals for amenorrhea appeared culturally associated. IMPLICATIONS: The 52-mg LNG-IUD and the TCu380A have very high contraceptive efficacy through 7 years. As an IUD, the unique side effects of the LNG-IUD are reduced bleeding, amenorrhea and symptoms compatible with hormonal contraceptives. Elsevier 2016-06 /pmc/articles/PMC5357727/ /pubmed/26916172 http://dx.doi.org/10.1016/j.contraception.2016.02.024 Text en © 2016 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Rowe, Patrick
Farley, Tim
Peregoudov, Alexandre
Piaggio, Gilda
Boccard, Simone
Landoulsi, Sihem
Meirik, Olav
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title_full Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title_fullStr Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title_full_unstemmed Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title_short Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A()()
title_sort safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the tcu380a()()
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357727/
https://www.ncbi.nlm.nih.gov/pubmed/26916172
http://dx.doi.org/10.1016/j.contraception.2016.02.024
work_keys_str_mv AT rowepatrick safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT farleytim safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT peregoudovalexandre safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT piaggiogilda safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT boccardsimone safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT landoulsisihem safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT meirikolav safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a
AT safetyandefficacyinparouswomenofa52mglevonorgestrelmedicatedintrauterinedevicea7yearrandomizedcomparativestudywiththetcu380a